Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1α,25-dihydroxycholecalciferol

Cancer

Volumn 119, Issue 3, 2013, Pages 563-574

  Ma, Yingyu ^a   Yu, Wei Dong ^a   Su, Bing ^a   Seshadri, Mukund ^a   Luo, Wei ^a   Trump, Donald L ^a   Johnson, Candace S ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

1, 25D3; E cadherin; invasion; metastasis; motility; squamous cell carcinoma

Indexed keywords

CALCITRIOL; GELATINASE A; GELATINASE B; UVOMORULIN;

ACTIN POLYMERIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL POLARITY; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GROWTH INHIBITION; LUNG METASTASIS; LUNG TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE; TUMOR GROWTH;

ANIMALS; CADHERINS; CALCITRIOL; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL SHAPE; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION, NEOPLASTIC; LUNG NEOPLASMS; MICE; MICE, INBRED C3H; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION;

EID: 84872910088     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27531     Document Type: Article

References (37)

1. Brown AJ, Dusso A, Slatopolsky E,., Vitamin D,. Am J Physiol. 1999; 277: F157-F175.
2. Peehl DM, Skowronski RJ, Leung GK, Wong ST, Stamey TA, Feldman D,. Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res. 1994; 54: 805-810.
3. Zhang X, Li P, Bao J, et al. Suppression of death receptor-mediated apoptosis by 1,25-dihydroxyvitamin D3 revealed by microarray analysis. J Biol Chem. 2005; 280: 35458-35468.
4. Shabahang M, Buras RR, Davoodi F, et al. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3. Cancer Res. 1994; 54: 4057-4064.
5. McGuire TF, Trump DL, Johnson CS,. Vitamin D-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. J Biol Chem. 2001; 276: 26365-26373.
6. Colston KW, Berger U, Coombes RC,. Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet. 1989; 1: 188-191.
7. Eisman JA, Barkla DH, Tutton PJ,. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Res. 1987; 47: 21-25.
8. McElwain MC, Modzelewski RA, Yu WD, Russell DM, Johnson CS,. Vitamin D: an antiproliferative agent with potential for therapy of squamous cell carcinoma. Am J Otolaryngol. 1997; 18: 293-298.
9. Bernardi RJ, Trump DL, Yu WD, McGuire TF, Hershberger PA, Johnson CS,. Combination of 1alpha,25-dihydroxyvitamin D with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling. Clin Cancer Res. 2001; 7: 4164-4173.
10. Hershberger PA, Yu WD, Modzelewski RA, Rueger RM, Johnson CS, Trump DL,. Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis. Clin Cancer Res. 2001; 7: 1043-1051.
11. Light BW, Yu WD, McElwain MC, Russell DM, Trump DL, Johnson CS,. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. Cancer Res. 1997; 57: 3759-3764.
12. Ma Y, Yu WD, Trump DL, Johnson CS,. 1,25D enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models. Cancer. 2010; 116: 3294-3303.
13. Nguyen DX, Bos PD, Massague J,. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009; 9: 274-284.
14. Sung V, Feldman D,. 1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration. Mol Cell Endocrinol. 2000; 164: 133-143.
15. Bao BY, Yeh SD, Lee YF,. 1Alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases. Carcinogenesis. 2006; 27: 32-42.
16. Ooi LL, Zhou H, Kalak R, et al. Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis. Cancer Res. 2010; 70: 1835-1844.
17. Ooi LL, Zheng Y, Zhou H, et al. Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis. Bone. 2010; 47: 795-803.
18. Zheng Y, Zhou H, Ooi LL, Snir AD, Dunstan CR, Seibel MJ,. Vitamin D deficiency promotes prostate cancer growth in bone. Prostate. 2011; 71: 1012-1021.
19. Hershberger PA, Modzelewski RA, Shurin ZR, Rueger RM, Trump DL, Johnson CS,. 1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. Cancer Res. 1999; 59: 2644-2649.
20. Ma Y, Yu WD, Hershberger PA, et al. 1Alpha,25-dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model. Mol Cancer Ther. 2008; 7: 3047-3055.
21. Schoenenberger CA, Bischler N, Fahrenkrog B, Aebi U,. Actin's propensity for dynamic filament patterning. FEBS Lett. 2002; 529: 27-33.
22. Pollard TD, Borisy GG,. Cellular motility driven by assembly and disassembly of actin filaments. Cell. 2003; 112: 453-465.
23. 3 inhibits angiogenesis in vitro and in vivo. Circ Res. 2000; 87: 214-220.
24. Bao BY, Yao J, Lee YF,. 1Alpha,25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis. Carcinogenesis. 2006; 27: 1883-1893.
25. Yudoh K, Matsuno H, Kimura T,. 1Alpha,25-dihydroxyvitamin D3 inhibits in vitro invasiveness through the extracellular matrix and in vivo pulmonary metastasis of B16 mouse melanoma. J Lab Clin Med. 1999; 133: 120-128.
26. Pendas-Franco N, Gonzalez-Sancho JM, Suarez Y, et al. Vitamin D regulates the phenotype of human breast cancer cells. Differentiation. 2007; 75: 193-207.
27. Young MR, Lozano Y,. Inhibition of tumor invasiveness by 1alpha,25-dihydroxyvitamin D3 coupled to a decline in protein kinase A activity and an increase in cytoskeletal organization. Clin Exp Metastasis. 1997; 15: 102-110.
28. Young MR, Halpin J, Hussain R, et al. Inhibition of tumor production of granulocyte-macrophage colony-stimulating factor by 1 alpha, 25-dihydroxyvitamin D3 reduces tumor motility and metastasis. Invasion Metastasis. 1993; 13: 169-177.
29. Rebsamen MC, Sun J, Norman AW, Liao JK,. 1Alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. Circ Res. 2002; 91: 17-24.
30. Birchmeier W, Hulsken J, Behrens J,. Adherens junction proteins in tumour progression. Cancer Surv. 1995; 24: 129-140.
31. Makrilia N, Kollias A, Manolopoulos L, Syrigos K,. Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest. 2009; 27: 1023-1037.
32. Cavallaro U, Christofori G,. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer. 2004; 4: 118-132.
33. Ma L, Young J, Prabhala H, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol. 2010; 12: 247-256.
34. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S,. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci U S A. 1995; 92: 7416-7419.
35. Palmer HG, Gonzalez-Sancho JM, Espada J, et al. Vitamin D promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol. 2001; 154: 369-387.
36. Nakagawa K, Sasaki Y, Kato S, Kubodera N, Okano T,. 22-Oxa-1alpha,25- dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. Carcinogenesis. 2005; 26: 1044-1054.
37. El Abdaimi K, Dion N, Papavasiliou V, et al. The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells. Cancer Res. 2000; 60: 4412-4418.